San Diego State University/University of California San Diego Joint Doctoral Program in Clinical Psychology, La Jolla, California, USA.
Division of Genetics/Dysmorphology, Rady Children's Hospital San Diego, San Diego, California, USA.
Cancer Rep (Hoboken). 2024 Sep;7(9):e2119. doi: 10.1002/cnr2.2119.
Cancer predisposition syndromes (CPS) impact about 10% of patients with pediatric cancer. Genetic testing (CPS-GT) has multiple benefits, but few studies have described parent and child knowledge and attitudes regarding CPS-GT decision-making. This study examined parent and patient CPS-GT decision-making knowledge and attitudes.
English- or Spanish-speaking parents of children with pediatric cancer and patients with pediatric cancer ages 15-18 within 12 months of diagnosis or relapse were eligible to participate. Seventy-five parents and 19 parent-patient dyads (N = 94 parents, 77.7% female, 43.6% Latino/a/Hispanic; 19 patients, 31.6% female) completed surveys measuring CPS-GT-related beliefs. Independent samples t-tests compared parent responses across sociodemographic characteristics and parent-patient responses within dyads.
Spanish-speaking parents were significantly more likely than English-speaking parents to believe that CPS-GT not being helpful (p < .001) and possibly causing personal distress (p = .002) were important considerations for deciding whether to obtain CPS-GT. Parents with less than four-year university education, income less than $75,000, or Medicaid (vs. private insurance) were significantly more likely to endorse that CPS-GT not being helpful was an important consideration for deciding whether to obtain CPS-GT (p < .001). Parents felt more strongly than patients that they understood what CPS-GT was (p = .01) and that parents should decide whether patients under 18 should receive CPS-GT (p = .002).
Spanish-speaking parents and parents with lower socioeconomic statuses were more strongly influenced by the potential disadvantages of CPS-GT in CPS-GT decision-making. Parents felt more strongly than patients that parents should make CPS-GT decisions. Future studies should investigate mechanisms behind these differences and how to best support CPS-GT knowledge and decision-making.
癌症易感性综合征(CPS)影响约 10%的儿科癌症患者。基因检测(CPS-GT)有多种益处,但很少有研究描述过父母和儿童对 CPS-GT 决策的知识和态度。本研究检查了父母和患者对 CPS-GT 决策的知识和态度。
符合条件的参与者包括英语或西班牙语为母语的儿科癌症患儿的父母和在诊断或复发后 12 个月内年龄在 15-18 岁的儿科癌症患者。共有 75 名父母和 19 对父母-患者(N=94 名父母,77.7%为女性,43.6%为拉丁裔/西班牙裔/拉丁裔;19 名患者,31.6%为女性)完成了测量 CPS-GT 相关信念的调查。独立样本 t 检验比较了父母在社会人口统计学特征方面的反应和父母-患者在对子中的反应。
西班牙语父母比英语父母更有可能认为 CPS-GT 没有帮助(p<0.001)和可能导致个人困扰(p=0.002)是决定是否进行 CPS-GT 的重要考虑因素。受教育程度低于四年制大学、收入低于 75,000 美元或医疗补助(与私人保险相比)的父母更有可能认为 CPS-GT 没有帮助是决定是否进行 CPS-GT 的重要考虑因素(p<0.001)。父母比患者更强烈地认为他们理解 CPS-GT 是什么(p=0.01),并且父母应该决定 18 岁以下的患者是否应该接受 CPS-GT(p=0.002)。
西班牙语父母和社会经济地位较低的父母在 CPS-GT 决策中更受 CPS-GT 潜在劣势的影响。父母比患者更强烈地认为父母应该做出 CPS-GT 决策。未来的研究应该调查这些差异背后的机制以及如何最好地支持 CPS-GT 知识和决策。